MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 2, 2004; DOI: 10.1124/mol.104.005926


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.005926v1
67/4/1018    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuda, N.
Right arrow Articles by Gando, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuda, N.
Right arrow Articles by Gando, S.


Received for publication August 9, 2004.
Revised November 30, 2004.
Accepted for publication December 1, 2004.

Nuclear Factor-{kappa}B Decoy Oligodeoxynucleotides Prevent Acute Lung Injury in Mice with Cecal Ligation and Puncture-Induced Sepsis

Naoyuki Matsuda 1, Yuichi Hattori 1*, Subrina Jesmin 1, Satoshi Gando 1

1 Hokkaido University

* Address correspondence to: E-mail: yhattori{at}med.hokudai.ac.jp

Abstract

The transcription factor nuclear factor-{kappa}B (NF-{kappa}B) plays a key role in expression of many inflammatory genes responsible for the pathophysiology of sepsis-induced acute lung injury. We investigated whether the introduction of synthetic double-stranded oligodeoxynucleotides (ODNs) with consensus NF-{kappa}B sequence as transcription factor decoy can prevent acute lung injury with suppression of pulmonary expression of multiple genes involved in its pathological process in a cecal ligation and puncture septic mouse model. NF-{kappa}B decoy ODNs were introduced with the aid of the haemagglutinating virus of Japan-envelope vector method. Northern blot analysis indicated that transfection of NF-{kappa}B decoy ODN, but not of its scrambled form, resulted in a significant inhibition of sepsis-induced gene overexpression of inducible nitric-oxide synthase (iNOS), cyclooxygenase-2, histamine H1-receptor, platelet activating factor receptor, and bradykinin B1 and B2 receptors in lung tissues. Histological damage in lungs (wall thickening, inflammatory infiltrate, and hemorrhage), increased pulmonary vascular permeability, and blood gas exchange impairment were clearly documented in mice after cecal ligation and puncture. These changes were strongly eliminated by the introduction of NF-{kappa}B decoy, but not of the scrambled ODN. The effects of the iNOS inhibitor FR260330 on these histological and functional derangements compared unfavorably with those of NF-{kappa}B decoy ODN transfection. Our results suggest that ODN decoy, acting as in vivo competitor for the transcription factor's ability to bind to cognate recognition sequence, may represent an effective strategy in the treatment of septic acute lung injury.


Key words: Histamine, Bradykinin, Nitric oxide synthases, NFkappaB, Cyclooxygenases





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics